Reata Pharmaceuticals Inc Update on CARDINAL Trial for Bardoxolone in Alport Syndrome

24/7/2017 8:30

Conference Call Reata Pharmaceuticals Inc

Reata Pharmaceuticals Inc Conference call will be held on Jul 24, 2017. During the earnings conference call's session Reata Pharmaceuticals Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Reata Pharmaceuticals Inc for this information
Schedule an online conference with QCONF conference service and get 5 free calls with online conferencing.
You should read the following discussion together with our consolidated financial statements and related notes and other financial information appearing in this prospectus. Some of the information contained in this discussion or set forth elsewhere in this prospectus includes forward-looking statements that involve risks and uncertainties. You should review the sections of this prospectus captioned "Risk Factors" and "Special Note Regarding Forward-Looking Statements" for a discussion of important factors that could cause our actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.    
Read more Conference Call

Reata Pharmaceuticals Inc (RETA)

2801 Gateway Drive, Irving Texas 75063, United States